
OPKO Health OPK
€ 1.00
0.85%
Quartalsbericht 2025-Q2
hinzugefügt 31.07.2025
OPKO Health EV 2011-2026 | OPK
EV Jährlich OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.62 B | 1.27 B | 1.27 B | 2.61 B | 4.2 B | 1.49 B | 2.67 B | 3.17 B | 4.76 B | 4.65 B | 5.41 B | 3.23 B | 1.97 B | 1.46 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.41 B | 1.27 B | 2.84 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 19.25 | 7.36 % | $ 205 M | ||
|
Agilent Technologies
A
|
45.8 B | $ 121.16 | 3.11 % | $ 36.8 B | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 17.41 | 3.45 % | $ 928 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 1.43 | -1.37 % | $ 1.9 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 24.69 | 4.93 % | $ 686 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 180.3 | 1.1 % | $ 8.94 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 2.2 | - | $ 9.73 M | ||
|
Danaher Corporation
DHR
|
145 B | $ 198.81 | 1.5 % | $ 142 B | ||
|
Medpace Holdings
MEDP
|
14 B | $ 517.09 | 3.16 % | $ 14.9 B | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
15.3 B | $ 130.78 | 3.01 % | $ 20.8 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.79 | 4.25 % | $ 444 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 8.22 | 2.75 % | $ 1.05 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 15.8 | 3.27 % | $ 478 M | ||
|
Natera
NTRA
|
5.53 B | $ 211.29 | 4.65 % | $ 20.8 B | ||
|
Guardant Health
GH
|
15.2 B | $ 85.71 | 4.26 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
990 K | $ 2.83 | -0.7 % | $ 91.8 K | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.04 | -1.92 % | $ 4.69 M | ||
|
Koninklijke Philips N.V.
PHG
|
13.2 B | $ 29.1 | 1.91 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 112.9 | 2.29 % | $ 9.31 B | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 266.64 | 0.93 % | $ 22.2 B | ||
|
Celcuity
CELC
|
5.57 B | $ 120.26 | -0.12 % | $ 5.62 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.49 | 3.88 % | $ 2.06 B | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 82.98 | 1.6 % | $ 5.6 B | ||
|
Senseonics Holdings
SENS
|
376 M | $ 6.79 | 0.97 % | $ 283 M | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Soleno Therapeutics
SLNO
|
2.13 B | $ 52.64 | -0.01 % | $ 2.68 B | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 193.31 | 0.23 % | $ 21.5 B | ||
|
ENDRA Life Sciences
NDRA
|
4.49 M | $ 4.94 | -4.74 % | $ 3.89 M | ||
|
Neuronetics
STIM
|
168 M | $ 1.42 | 2.16 % | $ 93.7 M | ||
|
National Research Corporation
NRC
|
432 M | $ 17.1 | 1.69 % | $ 383 M |